Camelot Portfolios, LLC Stryker Corp Transaction History

Camelot Portfolios, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$324.3 - $354.67 $285,708 - $312,464	881 New	881 $299,000
Q4 2023 Jan 23, 2024	BUY	$253.85 - $299.46 $223,641 - $263,824	881 New	881 $263,000
Q2 2023 Jul 25, 2023	BUY	$271.49 - $305.09 $239,182 - $268,784	881 New	881 $268,000
Q2 2022 Jul 18, 2022	SELL	$194.09 - $276.37 $170,993 - $243,481	-881 Closed	0 $0
Q1 2021 Apr 21, 2021	SELL	$221.01 - $248.82 $6,851 - $7,713	-31 Reduced 3.4%	881 $215,000
Q4 2020 Jan 27, 2021	BUY	$202.01 - $245.04 $184,233 - $223,476	912 New	912 $223,000

2,231

284M

1.35M

1.6M

Ticker SYK
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 378,320,992
Market Cap $136B
Description
Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products c...

Get notified when there are updates to the investment portfolio of Camelot Portfolios, LLC, based on Form 13F filings with the SEC.

Stay updated on Camelot Portfolios, LLC with notifications on news.